Lower Limb Claudication Due to Iliac Artery Occlusive Disease

  • Marcus Brooks
  • Fabien Koskas

Case Report

A 63-year-oldman presents with a history of worsening pain in his left buttock, thigh and calf on walking. During the preceding 3 months, following the introduction of a beta-blocker for newly diagnosed hypertension, the distance he could walk at a “normal” pace had reduced from 200 to 100 m. The pain ceased almost immediately after stopping walking and appeared again after the same interval. A systemic enquiry revealed recently diagnosed hypertension and life-long history of heavy smoking. He had never experienced cerebro-vascular or cardiac symptoms.

Clinical examination revealed sinus rhythm, full upper limb pulses, a diminished left femoral pulse and absent left popliteal and pedal pulses. The right leg pulses were normal. Both feet appeared well perfused. No bruits were audible in the abdomen or groins. The abdominal aorta was not aneurismal. Ankle pressure brachial indices were 0.74 on the left and 0.93 on the right at rest. On treadmill walking for 100 m the left...


  1. 1.
    Kannel WB, Shurtleff D. The Framingham Study. Cigarettes and the development of intermittent claudication. Geriatrics. 1973;28:61–8.PubMedGoogle Scholar
  2. 2.
    Mathieson FR, Larsen EE, Wulff M. Some factors influencing the spontaneous course of arterial vascular insufficiency. Acta Chir Scand. 1970;136:303–8.Google Scholar
  3. 3.
    Joseph AM, Norman SM, Ferry LH, et al. The safety of trans-dermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996;335:1793–8.CrossRefGoogle Scholar
  4. 4.
    Housley E. Treating claudication in five words. BMJ. 1988;296(6635):1483–4.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Gardener AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. JAMA. 1995;274:975–80.CrossRefGoogle Scholar
  6. 6.
    Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2000;2:CD000990.Google Scholar
  7. 7.
    Radark K, Deck C. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomised control trials. Arch Intern Med. 1991;151:1769–76.CrossRefGoogle Scholar
  8. 8.
    Kannel WB, McGhee DL. Update on some epidemiological features of intermittent claudication in subjects with peripheral vascular disease. J Am Geriatr Soc. 1985;22:13–8.CrossRefGoogle Scholar
  9. 9.
    Anti-platelet Trialists Collaboration. Collaboration overview of randomised trials on antiplatelet therapy. 1. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various catagories of patients. BMJ. 1994;308:81–106.CrossRefGoogle Scholar
  10. 10.
    CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1328–39.CrossRefGoogle Scholar
  11. 11.
    Visseren FL, Eikelboom BC. Oral anticoagulant therapy in patients with peripheral artery disease. Semin Vasc Med. 2003;3(3):339–44.CrossRefPubMedGoogle Scholar
  12. 12.
    Scandinavian Simvastatin Survival Group Study. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–9.Google Scholar
  13. 13.
    Sacks FM, Pfeffer MA, Moyle LA, et al. For the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Cameron HA, Waller PC, Ramsey LE. Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials. Br J Clin Pharmacol. 1988;26:569–76.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Strandness DE, Dalman RL, Panian S, et al. Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study. Vasc Endovasc Surg. 2002;36(2):83–91.CrossRefGoogle Scholar
  16. 16.
    Van der Zaag ES, Legemate DA, Nguyen T, et al. Aortoiliac reconstructive surgery based upon the results of duplex scanning. Eur J Vasc Endovasc Surg. 1998;16:383–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Catalano C, Fraioli F, Laghi A, et al. Infrarenal aortic and lower-limb arterial disease: diagnostic performance of multi-detector row CT angiography. Radiology. 2004;231:555–63.CrossRefPubMedGoogle Scholar
  18. 18.
    Nicholson T, Downes M. Contrast nephrotoxicity and iso-osmolar contrast agents: implications of NEPHRIC. Clin Radiol. 2003;58:659–60.CrossRefPubMedGoogle Scholar
  19. 19.
    Willmann JK, Wildermuth S, Pfammater T, et al. Aorto-iliac and renal arteries: prospective intraindervidual comparison of contrast-enhanced three-dimensional MR angiography and multidetector row CT angiography. Radiology. 2003;226:798–811.CrossRefPubMedGoogle Scholar
  20. 20.
    Dormandy JA. Management of Peripheral Arterial Disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). Eur J Endovasc Surg. 2000;19(Suppl A):S1–S244.Google Scholar
  21. 21.
    Rutherford RB, Durham JA, Kumpe DA. Endovascular intervention for lower extremity ischaemia. In: Rutherford RB, editor. Vascular surgery. 4th ed. Philadelphia: WB Saunders; 1995. p. 858–74.Google Scholar
  22. 22.
    Nevelsteen A, Wouters L, Suy R. Aortofemoral Dacron reconstruction for aorto-iliac occlusive disease: a 25 year survey. Eur J Vasc Surg. 1991;5:179–86.CrossRefPubMedGoogle Scholar
  23. 23.
    McCarthy MJ, Olojugba D, Loftus IM, et al. Lower limb surveillance following autologous vein bypass should be life long. Br J Surg. 1998;85:1369–72.CrossRefPubMedGoogle Scholar
  24. 24.
    Greenhalgh RM, Belch JJ, Brown LC, et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg. 2008;36(6):680–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Graham R. Case of obstructed aorta. Communicated by Sir G Blane. London: Medico-Chirurgical Transactions; 1814.Google Scholar
  26. 26.
    Leriche R. De la résection du carrefour aortico-iliaque avec double sympathectomie lombaire pour thrombose artéritique la l’aorte: le syndrome de l’oblitération termino-aortique par artérite. La presse médicale, Paris. 1940;48:601–7.Google Scholar
  27. 27.
    Ricco JB. Unilateral iliac artery occlusive disease; a randomised multi-centre trial examining direct revascularisation versus crossover bypass. Ann Vasc Surg. 1992;16:841–52.CrossRefGoogle Scholar
  28. 28.
    Smeets L, de Borst GJ, Vries JP, et al. Remote iliac artery endarterectomy: seven year results of a less invesive technique for iliac artery occlusive disease. J Vasc Surg. 2003;38:1297–304.CrossRefPubMedGoogle Scholar
  29. 29.
    Loggia M, Javerliat I, DiCentra I, et al. Total laparoscopic bypass for aorto-iliac occlusive lesions: 93 case experience. J Vasc Surg. 2004;40:899–906.CrossRefGoogle Scholar
  30. 30.
    Tetteroo E, van der Graff Y, Bosch JL, et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac artery occlusive disease. Lancet. 1998;18:499–505.Google Scholar
  31. 31.
    Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–S67.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Vascular SurgeryUniversity Hospitals Bristol NHS Foundation TrustBristolUK
  2. 2.Service of Vascular Surgery, Groupe Hospitalier Pitié-SalpétrièreParisFrance

Personalised recommendations